Humana vs United Health Products

Humana and UnitedHealth Group are two major players in the health insurance and healthcare services industry. Both companies offer a range of products and services, including health insurance plans, wellness programs, and pharmacy benefits management. Investors interested in the healthcare sector may consider comparing the stocks of Humana and UnitedHealth Group to determine which company may offer the best investment opportunity. Factors to consider when evaluating these stocks may include financial performance, market share, growth potential, and industry trends.

Humana or United Health Products?

When comparing Humana and United Health Products, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Humana and United Health Products.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Humana has a dividend yield of 1.37%, while United Health Products has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Humana reports a 5-year dividend growth of 12.10% year and a payout ratio of 25.48%. On the other hand, United Health Products reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Humana P/E ratio at 18.13 and United Health Products's P/E ratio at -12.78. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Humana P/B ratio is 1.86 while United Health Products's P/B ratio is -11.75.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Humana has seen a 5-year revenue growth of 1.07%, while United Health Products's is -1.00%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Humana's ROE at 10.37% and United Health Products's ROE at 100.97%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $251.24 for Humana and $0.09 for United Health Products. Over the past year, Humana's prices ranged from $213.31 to $530.54, with a yearly change of 148.72%. United Health Products's prices fluctuated between $0.08 and $0.29, with a yearly change of 258.02%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.